Fingerprint
Dive into the research topics of 'Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response
Lior Katz, Javier P. Gisbert, Beth Manoogian, Kirk Lin, Casper Steenholdt, Gerassimos J. Mantzaris, Ashish Atreja, Yulia Ron, Arun Swaminath, Somal Shah, Ailsa Hart, Peter Laszlo Lakatos, Pierre Ellul, Eran Israeli, Mads Naundrup Svendsen, C. Janneke Van Der Woude, Konstantinos H. Katsanos, Laura Yun, Epameinondas V. Tsianos, Torben Nathan
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
129
Scopus
citations